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OBJECTIVES: Tumor-associated macrophages that generally exhibit an alternatively activated (M2) phenotype have
been linked to tumor progression and metastasis. However, the role of M2-polarized macrophages in the growth
and metastasis of lung adenocarcinoma remains enigmatic. The aim of this study was to explore the effect of M2
macrophages on the proliferation and migration of mouse Lewis lung carcinoma cells and tumor-induced
lymphangiogenesis.
METHODS: Trypan blue staining and the Transwell migration assay were performed to evaluate the effects of
activated (M1 or M2) macrophages on the proliferation and migration of Lewis cells. Furthermore, vascular
endothelial growth factor-C expression in Lewis cells and nitric oxide secretion from activated macrophages were
detected during the co-culture assay. Following treatment with activated macrophages, lymphatic endothelial cells
differentiated into capillary-like structures, and the induction of Lewis cell migration was assessed using a two-
dimensional Matrigel-based assay.
RESULTS: In the co-culture Transwell system, the proliferation and migration of Lewis cells were promoted by M2
macrophages. Moreover, the co-culture significantly increased the expression of vascular endothelial growth factor-
C by Lewis cells and reduced the secretion of nitric oxide from M2 macrophages, which subsequently led to the
capillary morphogenesis of lymphatic endothelial cells. Interestingly, following co-culture with Lewis cells, the
function of RAW264.7 cells was polarized toward that of the M2 macrophage phenotype.
CONCLUSION: M2-polarized macrophages promoted the metastatic behavior of Lewis cells by inducing vascular
endothelial growth factor-C expression. Thus, the interruption of signaling between M2 macrophages and Lewis
cells may be considered to be a new therapeutic strategy.
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INTRODUCTION
Metastasis is the main cause of cancer-related mortality
secondary to malignancy. It has been clearly demonstrated
that inflammatory cells in the tumor microenvironment play
an important role in tumor growth, progression, and meta-
stasis. Within the tumor stroma, tumor-associated macro-
phages (TAMs) constitute a pivotal class of inflammatory cells,
and compelling evidence has emerged to suggest that TAMs
play a promoting role in processes such as carcinogenesis,
tumor growth, angiogenesis, and lymphangiogenesis and are
the key regulators of the metastatic phenotype of cancer cells
(1-3). Moreover, in lung adenocarcinoma, this pro-tumor role
of TAMs is further supported by clinical studies demonstrat-
ing a correlation between high macrophages numbers in
tumor tissue and poor patient prognosis (4-7). However, the
activated phenotype and polarization status of TAMs in solid
tumors are not well-understood, and the results of previous
reports have often been contradictory.
There appear to be at least two different subpopulations
of activated macrophages coexisting in the tumor micro-
environment (8,9). The first subpopulation is referred to as
classically activated macrophages (M1 macrophages), which
are characterized by the IL-12high, IL-23high, and IL-10low
phenotype, and these macrophages can produce tumor
necrosis factor (TNF)-a and nitric oxide (NO). Traditionally,
M1 macrophages are regarded as potent effector cells that
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are able to kill microorganisms and tumor cells. The other
subpopulation is termed alternatively activated macrophages
(M2 macrophages). Exposure to IL-4, IL-13, vitamin D3,
glucocorticoids, or transforming growth factor-b (TGF-b)
decreases the antigen-presenting capability of macrophages
and up-regulates the expression of macrophage mannose
receptors (MMR, also known as CD206), scavenger receptors
(SR-A, also known as CD204), CD163, dectin-1 and DC-SIGN
(10). M2-polarized macrophages have the IL-12low, IL-23low,
and IL-10high phenotype and are involved in stromal for-
mation, tissue repair, tumor growth, angiogenesis, lymphan-
giogenesis, and immunosuppression. Although these two
subpopulations have been extensively characterized, the role
of M1- or M2-polarized macrophages in the progression and
metastasis of lung cancer has not been clearly elucidated.
Here, we investigated the effect of M2-polarized macro-
phages on the metastatic behavior of Lewis lung carcinoma
(LLC) cells in a co-culture Transwell system and found that
M2 macrophages could promote the proliferation and
migration of LLC cells and stimulate tumor-induced lym-
phangiogenesis by inducing VEGF-C (vascular endothelial
growth factor-C) expression.
MATHERIAL AND METHODS
Cell lines
Mouse RAW264.7 macrophages and LLC cells were
purchased from the American Type Culture Collection
(ATCC; Manassas, VA, USA) and were maintained in
Dulbecco’s Modified Eagle Medium (DMEM) containing
10% fetal bovine serum (FBS; both from Invitrogen, Carlsbad,
CA, USA). The isolation and culture of lymphatic endothelial
cells (LECs) were performed as described in our previous
report (11). Briefly, female Balb/c mice were intraperitone-
ally injected with emulsified incomplete Freund’s adjuvant
(Sigma-Aldrich, St Louis, MO, USA) to induce lymphan-
gioma formation. After 30 days of induction, tumors in the
peritoneal cavity were removed and mechanically disrupted,
and LECs were isolated and resuspended in endothelial cell
basal medium-2 (EBM-2; Cambrex BioScience, Wokingham,
UK) supplemented with 20% FBS and 50 ng/ml endothelial
cell growth supplement (Cambrex BioScience, Wokingham,
UK), and these cells were grown at 37 C˚ in a humidified
atmosphere of 5% CO2. LECs were used in appropriate
experiments or cultivated until the fourth passage.
Activation of RAW264.7 macrophages
As described in our previous study (12), M2- or M1-
polaried macrophages were prepared by stimulating
RAW264.7 macrophages with 10 IU/ml mouse recombinant
IL-4 (Cytolab Ltd., Rehovot, Israel) or 100 IU/ml IFN-c
(Cytolab Ltd., Rehovot, Israel) plus l0 ng/ml LPS (Sigma-
Aldrich, St Louis, MO, USA) overnight, respectively.
Cell proliferation assay
A Transwell system with a porous (0.4 mm pore size)
polycarbonate membrane filter (Millipore Corp., Bedford,
MA, USA) and 24-well plastic tissue culture plates were used
for the macrophage-LLC co-cultures. LLC cells were first
seeded into 24-well culture plates at a subconfluent density of
16104 cells/well. Four hours later, different types of activated
macrophages (16104/well) were washed three times in PBS
and then added to the upper chambers. The resultant four
groups were as follows: i) blank control group, ii) M1 group,
iii) M2 group, and iv) RAW264.7 group. The proliferation of
the LLC cells was determined by counting triplicate plates at
the indicated times during a 6-day culture period using a
Coulter counter. Cell viability for each experiment was
determined by trypan blue staining. The results presented
represent the mean values from three separate experiments.
Cell migration assay
The migration of LLC cells was assayed in Transwell cell
culture chambers with a porous (8.0 mm pore size) poly-
carbonate membrane filter (Millipore Corp., Bedford, MA,
USA), as described previously (13). Briefly, 16104 LLC cells
were seeded in the upper chamber. Following attachment,
1 ml of culture supernatant was added to the lower well.
After 24 h of incubation, the membranes were removed and
stained with hematoxylin and eosin (H&E), and the number
of cells that had invaded the lower chamber was counted in
three randomly selected fields under light microscopy.
Immunocytochemistry for VEGF-C expression
Cell smears were prepared from the co-cultures described
above and were then immunostained with a mouse mono-
clonal VEGF-C antibody (1:100; Boster, Wuhan, CHINA) at
4 C˚ overnight. The cells were subsequently exposed to a
biotinylated secondary antibody for 20 min, which was
followed by treatment with streptavidin peroxidase. For color
development, the slides were stained with 3,3’-diaminoben-
zidine (DAB) and then counterstained with H&E. A red-
brown precipitate in the cytoplasm of the LLC cells indicated
a positive reaction. The true color multi-function CMIAS
pathological image-analyzing system was used for spectro-
densitometry, and the integral optical density (IOD) repre-
sented the relative intensity of positive VEGF-C expression.
Five magnified fields (2006) were selected randomly, and the
mean values were calculated for statistical comparison.
NO production
As described previously, NO production was estimated
according to the accumulation of NO2
- in the medium after
24 h of macrophage activation using the Greiss reagent (9).
Briefly, equal volumes of culture supernatant and Greiss
reagent (100 ml) were mixed for 10 min at room tempera-
ture. The absorbance at 540 nm was measured using a
Labsystems Multiscan Ascent assay plate reader. A graded
solution of NO2 was used to construct a standard curve, and
the results presented represent the mean values from three
separate samples.
In vitro capillary morphogenesis assay
LEC differentiation into capillary-like structures was
determined using a two-dimensional Matrigel-based assay.
Initially, ice-cold growth factor-reduced Matrigel was placed
into each well of a 24-well tissue culture plate. The plates were
maintained at 37 C˚ until the Matrigel had fully solidified.
LECs were harvested in complete media, washed once, and
then resuspended in serum-free EBM media. LECs were
mixed with media collected from LLC cells, and they were
subsequently treated with activated macrophage-conditioned
medium for 24 h. After 24 h of incubation, the formation of
tube-like structures was monitored by microscopic observa-
tion at 1006magnification, and more than 12 different fields
in each well were photographed to measure the length of the
tube-like structures, as described previously (14).
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Statistical analysis
The measurement data are expressed as the means¡SD.
Differences were compared using a one-way ANOVA
analysis followed by Student’s t-test. A p-value ,0.05 was
considered to be statistically significant. All statistical
analyses were performed using SPSS 17.0 software (SPSS
Inc., Chicago, IL, USA).
RESULTS
M2 macrophages induce the proliferation of LLC
cells
To evaluate the effect of activated macrophages on the
proliferation of LLC cells, cell viability was determined with
trypan blue staining to create a growth curve. As shown in
Figure 1, the addition of both M2 macrophages and RAW264.7
cells significantly increased the proliferation of LLC cells
compared to the control (p,0.05). Furthermore, the prolifera-
tion velocity of LLC cells in co-culture with M2 macrophages
was greater than that observed for the RAW264.7 co-culture
group. However, the proliferation of LLC cells was inhibited
following co-culture with M1 macrophages.
M2 macrophages induce migration of LLC cells
To determine the effect of activated macrophages on the
migratory behavior of LLC cells, we utilized a Transwell
system to evaluate cell migration. As shown in Figure 2, M2
macrophages and RAW264.7 cells significantly increased
the migratory potential of LLC cells compared to the control
condition (p,0.01), whereas M1 macrophages did not alter
the migration of LLC cells. Furthermore, the migratory rate
of LLC cells cultured with M2 macrophages was faster than
that observed for the culture with RAW264.7 cells (p,0.05).
M2 macrophages increase VEGF-C expression in LLC
cells
We next explored whether activated macrophages could
induce the production of pro-lymphangiogenic stimuli in
LLC cells, which would lead to the capillary morphogenesis
of LECs. Following co-culture, the numbers of LLC cells co-
cultured M2 macrophages or RAW264.7 cells were increased
in comparison to the non-co-cultured group and the M1
macrophage co-culture group. In addition, changes in the
morphology of LLC cells cultured with M2 macrophages or
RAW264.7 cells were noted. Next, we sought to evaluate the
expression of VEGF-C, a primary lymphatic vessel growth
factor, using immunocytochemistry. With this technique,
IOD values were used to represent the level of VEGF-C
expression in LLC cells. As shown in Figure 3, the IODs
for VEGF-C in the blank control, M1, M2 and RAW264.7
Figure 1 - Dynamic changes in LLC cell growth. Following culture
of a blank control sample or co-culture with M1, M2, and
RAW264.7 macrophages, the LLC cell number and viability were
evaluated by trypan blue staining at the indicated times during a
6-day period. The data shown represent three experiments.
* p,0.05 and ** p,0.01 compared to the blank control.
Figure 2 - Effect of activated macrophages on the migration of LLC cells. (A) Following the culture of a blank control or the addition of
M1 macrophages, M2 macrophages or RAW264.7 macrophages for 24 h, invasive LLC cells on the outer surface of the upper chambers
were stained with H&E (2006). (B) Comparison to the penetrated cells. The data shown represent three experiments. ** p,0.01
compared to the blank control.
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co-cultured groups were 44.53¡8.76, 42.19¡3.52, 264.19¡
13.36, and 118.51¡10.82, respectively. In comparison to the
control condition, co-culture with M2 and RAW264.7 macro-
phages increased the expression of VEGF-C by LLC cells
(p,0.05); however, M2 macrophages had a more pronounced
effect on the expression of VEGF-C than the RAW264.7
macrophages. No significant change in VEGF-C expression
was observed in the control or M1 macrophage group.
M2 macrophages do not produce NO
We measured the accumulation of NO2
– in culture super-
natants using the Greiss assay. M1 macrophages produced
relatively high levels of NO (234.12¡14.83 mmol/L), whereas
M2 macrophages, RAW264.7 cells and the blank control
culture failed to generate significant levels of NO.
M2 macrophages stimulate tumor-induced
lymphangiogenesis
Using a two-dimensional Matrigel-based assay, we next
evaluated the differentiation of LECs into capillary-like
structures. As shown in Figure 4 after 24 h of culture, the
network of tube-like structures in the M2 macrophage and
the RAW264.7 co-culture groups was more extensive than
that observed in the M1 macrophage or control group
(p,0.05), and there were no significant differences between
the two former and latter culture conditions.
DISCUSSION
Our data demonstrate that M2-polarized macrophages
induced metastatic behavior in lung cancer cells by stimulat-
ing their proliferation and migration. In the past decade,
various studies have suggested that TAMs adopt the M2-
polarized phenotype (15-17); however, more recent reports
have described the polarization of activated TAMs (i.e., M1
and M2) within the tumor microenvironment (18-21). Our
previous study demonstrated that M2-polarized TAMs in lung
adenocarcinomas were associated with peritumoral lymphan-
giogenesis and a poor prognosis (22). Alternatively, in mouse
Lewis lung adenocarcinoma, activated TAMs were shown to
induce peritumoral lymphangiogenesis via the up-regulation
of VEGF-C expression and the promotion of lymphangiogen-
esis-related behaviors in LECs (12). Moreover, recent studies
have revealed that macrophages could enhance the invasive-
ness of cancer cells both in vitro and in vivo (23-26). It has also
been shown that the presence of macrophages within tumors
can be associated with a histologically more malignant pheno-
type that is characterized by an extensive stromal reaction,
disorganized matrix deposition and neovascularization (27).
Craig et al. (28) also found that the presence of macrophages
increased tumor microvascular density in vivo and enhanced
the rate of tumor growth. In support of these findings, the
current study demonstrated that M2-polarized macrophages,
but not M1 macrophages, could increase the proliferation and
invasion of LLC cells. Moreover, following co-culture, non-
activated RAW264.7 macrophages were polarized towards the
M2 phenotype and LLC cells exhibited higher proliferative
rates and a greater invasive potential. In a previous report,
Hagemann et al. (18) found that ovarian cancer cells were
able to polarize co-cultured macrophages towards a tumor-
associated phenotype, which resulted in a TAM activation
pattern similar to that found in ovarian tumors in vivo. Hence,
our results suggested that RAW264.7 macrophages and LLC
cells could mutually alter each other’s behaviors.
Furthermore, our data indicated that M2-polarized macro-
phages could induce the expression of VEGF-C in LLC cells,
although they lost the ability to produce NO. In a previous
report, Chen et al. (29) confirmed that the expression of specific
genes, such as IL-6, IL-8, VEGF, VEGF-C, matrix metallopro-
teinase (MMP)-9 and MMP-1, was upregulated in non-small
cell lung cancer following co-culture with macrophages. In
another study, Jedinak et al. (24) demonstrated that activated
Figure 3 - VEGF-C expression by LLC cells induced following exposure to activated macrophages. (A) VEGF-C could be detected in the
blank control and in the M1, M2, and RAW264.7 macrophage co-cultured groups. (B) Comparison of the IODs for VEGF-C. The data
shown represent three experiments. * p,0.05 and ** p,0.01 compared to the blank control.
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macrophage-conditioned medium markedly induced the
proliferation and migration of human HCT116 colon cancer
cells and increased the activation of NF-kB and the secre-
tion of VEGF from colon cancer cells, which subsequently
induced the capillary morphogenesis of human aortic
endothelial cells. In this study, we demonstrated that both
M2 macrophages and RAW 264.7 cells could increase the
expression of VEGF-C by LLC cells, which may contribute
to the changes observed related to their metastatic behavior.
Moreover, in addition to VEGF-C, other factors secreted by
LLC cells or M2 macrophages were also likely responsible
for the observed behavioral changes of LLC cells, although
these factors were not specifically examined in the present
study. Furthermore, the high NO levels detected in the
M1 macrophage and LLC cell co-culture supernatant were
likely responsible for the inhibition of the metastatic
behavior of LLC cells.
In addition, our data showed that M2-polarized macro-
phages stimulated tumor-induced lymphangiogenesis in part
via the induction of VEGF-C expression. Lymphangiogenesis
is considered the initial step and a necessary event in
lymphatic and regional lymph node metastasis (30,31).
Similar to angiogenesis, lymphangiogenesis consists of a
complex multistep process involving endothelial prolifera-
tion, migration, and tube-like formation. In addition, these
processes can be triggered by the binding of lymphangiogenic
growth factors, such as VEGF-C and VEGF-D, to their
receptors (including VEGFR-2 and VEGFR-3), which leads
to lymphatic spread (32,33). Studies have also shown that
macrophages support lymphangiogenesis in two ways: by
transdifferentiation and direct incorporation into the endothe-
lial layer or by stimulating the division of preexisting local
LECs (34,35). Schoppmann et al. (36,37) reported that the
peritumoral inflammatory reaction and VEGF-C-expressing
TAMs increase tumor lymphangiogenesis and lymphovascu-
lar invasion in cervical cancer and invasive breast cancer. In
the current study, we demonstrated that following interaction
with M2 macrophages or RAW 264.7 cells, LLC cells
expressed higher levels of VEGF-C, and this may have led
to increased tumor-induced lymphangiogenesis.
In conclusion, the interaction between M2 macrophages
and lung adenocarcinoma cells induced the metastatic
behavior of Lewis lung adenocarcinoma. Activated M2
macrophages have been shown to be involved in tumor
progression and metastasis, which implies that they have the
potential to become new targets for tumor therapy (38). Thus,
the modulation of macrophage phenotype and function via
the administration of immunoregulatory stimuli may provide
therapeutic anti-cancer strategies. However, further study is
necessary to investigate the detailed mechanisms of these
interactions and to evaluate whether similar mechanisms are
applicable in vivo.
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